Delivery Order SPE2DR25D3201-SPE2DR26FT4YJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,144.62 to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units) on November 24, 2025, with a completion date of November 25, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,322.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lyrica 75 mg capsules in unit dose packaging (100 count) on December 18, 2025, with completion scheduled for December 19, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,183.60 to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count units) under a firm fixed-price contract valued at $1,144.58. The award was made on December 2, 2025, with an ultimate completion date of December 3, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,537.11 to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsule unit dose packages (100 count) on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Lyrica 25 mg capsules (90-count units) valued at $1,758.84. This firm fixed-price delivery order, with an ultimate completion date of December 16, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was not...
- The Defense Logistics Agency awarded a delivery order valued at $2,240.63 to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units). This firm fixed-price delivery order, awarded on December 11, 2025, with completion targeted for December 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $3,119.78 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on December 16, 2025, with completion expected by December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds...
- The Defense Logistics Agency awarded a delivery order valued at $4,746.84 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,614.55 to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90 count) on October 30, 2025, with completion targeted for October 31, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4YJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,150.61 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count units) on December 26, 2025, with an ultimate completion date of December 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this requirement as a child delivery order under a larger contract vehicle. This award is associated with AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this arrangement, AmerisourceBergen supplies pharmaceutical products to multiple federal customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's extensive capability to meet federal medical procurement requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 12/25/25 |